Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by LiquidRealityon Nov 15, 2018 5:04am
88 Views
Post# 28978027

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:IR

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:IRI dont know why everyone on here keeps saying they will do a pp and then put news out. This makes no sense. If the stock was trading a lot higher than .25 then maybe. They have clearly hired all this expensive IR for a reason. That reason is to get the stock price up and do a large financing. No IR firm is that good that they could get SVA going without some legit news. If it was a pump and dump IR firm then maybe. But Trout is not that kind of firm. Also don’t think for a moment the insiders only have shares in their names. They have personal shares in their brothers wife’s nephews account or good friends accounts also, and want the price up to make money just like everyone else. If SVA is going to start their patient trials and move forward (as Bioteck mentions, we know this works, they’ve done it before) they are going to need a boatload of money. Each patient costs $1m! Milestone hit, news out, higher price, financing.

Bioteck has some good points, however he is assuming SVA is never really going to amount to anything and this is a pure stock play. He is also assuming the institutions or brokers have power over SVA. If the science checks out, SVA will be in the driver’s seat. If it doesn’t, then they are. However, assuming he is correct then there are still at least a few doubles to be made. You just have to make sure you SELL. SVA is an old Calgary Blackmont Capital and George Adams play. I have made good money trading his (now) VPT, but you have to be patient and make sure you SELL on large price spikes and volume. SVA, VPT, AMF, RVX. I have played all those Blackmont deals. I played RVX from .25 to $30. Dreams can come true. RVX was just a great triple recently and they have raised over $100m out of China in the past few years. The thing I agree with Bioteck the most is the rollback. If all the smack talk of NASDAQ is going to come true, they will have to do at least a 10-1 roll. Then they better have some HUGE news to back this up, or its hard dump dump time and buy back afterwards.
 
95% of the people on this board are here because they are long, believe in the story, and want the price to go up. Really, if you’re not a shareholder why would you be here? We are all wishing for the $100 dream. The good news is, there are some big names in here with some very smart people. I have also personally raised a lot of money for JDRF and know they are extremely tight with their money. They wouldn’t have given SVA a penny unless they thought their story was legit and worthy. I will go out on a limb and say a double is coming VERY soon. Don’t be greedy. Sell at least half your position, and let the rest ride for the home run.  GLTA


Bullboard Posts